| 1 |
glucagon-like peptide-1
(6967 times)
|
Endocrinology
(1770 times)
|
GIP (1067 times)
DPP-4 (531 times)
T2DM (434 times)
|
1987 Identification and localization of glucagon-like peptide-1 and its receptor in rat brain.
|
| 2 |
glucagon-like peptide-1 receptor
(16 times)
|
Pharmacology
(3 times)
|
DPP-4 (7 times)
IR (4 times)
T2DM (3 times)
|
2009 Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons.
|
| 3 |
glucagon-like protein-1
(7 times)
|
Gastroenterology
(3 times)
|
BMI (1 time)
CCK (1 time)
Exd4 (1 time)
|
2005 Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
|
| 4 |
GATA-like protein-1
(3 times)
|
Embryology
(1 time)
|
---
|
2006 GLP-1: a novel zinc finger protein required in somatic cells of the gonad for germ cell development.
|
| 5 |
gastrointestinal hormones today:glucagon-like peptide-1
(1 time)
|
Drug Therapy
(1 time)
|
GIP (1 time)
|
2011 Incretins yesterday, pleiotropic gastrointestinal hormones today:glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).
|
| 6 |
ghrelin, andglucagonlike peptide 1
(1 time)
|
Nutritional Sciences
(1 time)
|
HA (1 time)
LA (1 time)
|
2019 Effect of Meal Acceptability on Postprandial Appetite Scores and Hormones of Male Participants with Varied Adiposity.
|
| 7 |
GLP-1 (1.5 nmol/kg body weight subcutaneously) plus placebo tablet
(1 time)
|
Metabolism
(1 time)
|
AUC (1 time)
DPP-4 (1 time)
|
2010 Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
|
| 8 |
GLP-1 antagonists
(1 time)
|
Endocrinology
(1 time)
|
MET (1 time)
OAD (1 time)
|
2019 Treatment intensification strategies after initial metformin therapy in adult patients with type-2 diabetes: results of the DPV and DIVE registries.
|
| 9 |
GLP-1 increased serum insulin at 270 minutes
(1 time)
|
Critical Care
(1 time)
|
---
|
2011 Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes.
|
| 10 |
GLP-1 response failed to reach significance
(1 time)
|
Endocrinology
(1 time)
|
ivGTT (1 time)
OGTT (1 time)
St-M (1 time)
|
1999 Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects.
|
| 11 |
GLP-1(7-36)
(1 time)
|
Vascular Diseases
(1 time)
|
DPP-4 (1 time)
GLP-1R (1 time)
|
2008 Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
|
| 12 |
GLP-1(7-36)amide
(1 time)
|
Biochemistry
(1 time)
|
---
|
2012 Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart.
|
| 13 |
GLP-1-Gly8
(1 time)
|
Biology
(1 time)
|
CHL (1 time)
|
2005 Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.
|
| 14 |
GLP-1-IR cells
(1 time)
|
Medicine
(1 time)
|
PYY (2 times)
IR (1 time)
|
2012 The developmental plasticity of colocalization pattern of peptide YY and glucagon-like peptide-1 in the endocrine cells of bovine rectum.
|
| 15 |
GLP-lAuc
(1 time)
|
Medicine
(1 time)
|
PYY (2 times)
AUC (1 time)
BMI (1 time)
|
2013 [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].
|
| 16 |
glucagon receptor like peptide-1
(1 time)
|
Psychiatry
(1 time)
|
HGO (1 time)
|
2014 Clozapine directly increases insulin and glucagon secretion from islets: implications for impairment of glucose tolerance.
|
| 17 |
glucagon-like peptide, do not eat
(1 time)
|
Pediatrics
(1 time)
|
HB (1 time)
NB (1 time)
|
2014 Tumor-associated energy homeostasis: hepatoblastoma and neuroblastoma affect glucose and lipid metabolism as well as ghrelin, GLP-1, and PYY in nude rats.
|
| 18 |
glucagon-like-peptide-1-antibody fusion proteins
(1 time)
|
Biotechnology
(1 time)
|
---
|
2011 Characterization of the proteases involved in the N-terminal clipping of glucagon-like-peptide-1-antibody fusion proteins.
|
| 19 |
Glucagon-related peptide 1
(1 time)
|
Biochemistry
(1 time)
|
---
|
2005 Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter.
|
| 20 |
incretins--glucagon-like peptide-1
(1 time)
|
Medicine
(1 time)
|
DPP-4 (1 time)
GIP (1 time)
|
2007 Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.
|
| 21 |
pbeta-GLP-1 and 1.5-1.7 times than TSTA
(1 time)
|
Pharmacology
(1 time)
|
ABP (1 time)
SP (1 time)
TSTA (1 time)
|
2011 Efficient GLP-1 gene delivery using two-step transcription amplification plasmid system with a secretion signal peptide and arginine-grafted bioreducible polymer.
|
A Search Service for Abbreviation / Long Form